Antimicrobial resistance (AMR) – the resistance of a microorganism to an antimicrobia drug that was originally effective for treatment of infections caused by it – threatens the effective prevention and treatment of infections caused by bacteria, parasites, viruses and fungi. It is an increasingly serious threat to global public health that requires action across all government sectors and society. This paper describes how the sector of Complementary and Alternative Medicine (CAM) can contribute to reducing the problem of AMR.

The CAM perspective on health and disease is essentially different from the conventional biomedical perspective. It is not just a difference in the technology and instruments used, but in the underlying paradigms, the basic concepts of and philosophical perspective.  Although CΑΜ represents a variety of different medical systems and therapies, the CAM modalities have a common denominator, i.e. their individualised holistic approach and their focus on promoting the individual’s health by assisting the person’s innate healing capacity.
Please read the EUROCAM’s document (PDF)Anhang

CAM-METHODS

Variety of Treatments

Today there are over eighty different complementary methods and alternative treatments. This also includes independent healing systems from different cultures and traditions. A common basis and unifying link throughout is holistic thinking.

PLANET HEALTH

For a Free and Healthy Europe

While the foundation for European legislation is under the control of the national states, together our states work to promote the free choice of therapy, choice of practitioner, and the option for self-care and self-help/improvement in both the public and private market.

ORGANIZATION

Who We Are and What We Do

As a European umbrella organization, ANME works on behalf of the common interests of citizens, patients, therapists, and manufacturers in the field of remedies and natural healing methods. We build capacity and raise awareness about the scope and versatility of and for natural medicine.

Pharmaceutical strategy for Europe

As a first step towards the adoption of a Pharmaceutical Strategy for Europe the Commission published on 2nd of July a roadmap, inviting interested citizens and stakeholders to share their views on the Strategy. Scheduled to be adopted before the end of the year, the overall objective of the Pharmaceutical Strategy for Europe is to help ensure Europe's supply of safe and affordable medicines and support the European pharmaceutical industry to remain an innovator and world leader.

Stella Kyriakides, Commissioner in charge of Health & Food Safety, said:

“By the end of the year, I will present an ambitious Pharmaceutical Strategy for Europe to ensure affordability, sustainability and security of supply. The coronavirus pandemic has showed us more than ever that we need to have a crisis-resistant system and the means to produce medicine within the EU to ensure timely access to essential medicines for our citizens and hospitals in all circumstances.”

Citizens, experts and stakeholders are invited to give, until 7 July 2020, their feedback to the roadmap through the Better Regulation Portal and consult the dedicated website for additional information and to follow updates. This roadmap will be followed by a public consultation.

Read more here…